Seroprevalence of coronavirus disease 2019 (COVID-19) among health care workers from three pandemic hospitals of Turkey
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
COVID-19 is a global threat with an increasing number of infections. Research on IgG seroprevalence among health care workers (HCWs) is needed to re-evaluate health policies. This study was performed in three pandemic hospitals in Istanbul and Kocaeli. Different clusters of HCWs were screened for SARS-CoV-2 infection. Seropositivity rate among participants was evaluated by chemiluminescent microparticle immunoassay. We recruited 813 non-infected and 119 PCR-confirmed infected HCWs. Of the previously undiagnosed HCWs, 22 (2.7%) were seropositive. Seropositivity rates were highest for cleaning staff (6%), physicians (4%), nurses (2.2%) and radiology technicians (1%). Non-pandemic clinic (6.4%) and ICU (4.3%) had the highest prevalence. HCWs in “high risk” group had similar seropositivity rate with “no risk” group (2.9 vs 3.5 p = 0.7). These findings might lead to the re-evaluation of infection control and transmission dynamics in hospitals.
Article activity feed
-
-
SciScore for 10.1101/2020.08.19.20178095: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: HCWs not willing to give consent, HCWs with a history of COVID-19 diagnosis without a confirmatory PCR test and those diagnosed within the last 14 days were excluded.
IRB: This study was approved by the ethics committee of the Umraniye Teaching and Research Hospital (approval number: 29.05.2020/10337).Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources For detection of SARS-CoV-2 IgG, chemiluminescent microparticle immunoassay was carried out according to manufacturer’s instructions and samples were run on the related instrument … SciScore for 10.1101/2020.08.19.20178095: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: HCWs not willing to give consent, HCWs with a history of COVID-19 diagnosis without a confirmatory PCR test and those diagnosed within the last 14 days were excluded.
IRB: This study was approved by the ethics committee of the Umraniye Teaching and Research Hospital (approval number: 29.05.2020/10337).Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources For detection of SARS-CoV-2 IgG, chemiluminescent microparticle immunoassay was carried out according to manufacturer’s instructions and samples were run on the related instrument (ARCHITECT, Abbott Laboratories, Abbott Park, IL, USA). Abbott Laboratoriessuggested: NoneStatistical Analysis: All statistical analyses were performed by SPSS version 22 software (Chicago, IL). SPSSsuggested: (SPSS, RRID:SCR_002865)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:Limitations: Even though a significant number of employees were tested, not all of the invited HCWs in these hospitals participated in the study. Screening larger cohorts from hospitals could serve more information to monitor the course of pandemic among HCWs.
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-